Factors influencing postoperative recurrence of early-stage non-small cell lung cancer

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi: 10.3322/caac.21660.
   PubMed Web of Science ®Google Scholar
• Liu CH, Peng YJ, Wang HH, et al. Heterogeneous prognosis and adjuvant chemotherapy in pathological stage I non-small cell lung cancer patients. Thorac Cancer. 2015;6(5):620–628. doi: 10.1111/1759-7714.12233.
   PubMed Web of Science ®Google Scholar
• Carnio S, Novello S, Papotti M, et al. Prognostic and predictive biomarkers in early stage non small-cell lung cancer: tumor based approaches including gene signatures. Transl Lung Cancer Res. 2013;2:372–381.
   PubMedGoogle Scholar
• Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg. 1995;60(3):615–622. doi: 10.1016/0003-4975(95)00537-u.
   PubMed Web of Science ®Google Scholar
• Uramoto H, Tanaka F. Recurrence after surgery in patients with NSCLC. Transl Lung Cancer Res. 2014;3:242–249.
   PubMedGoogle Scholar
• Hayashi N, Egami H, Kai M, et al. No-touch isolation technique reduces intraoperative shedding of tumor cells into the portal vein during resection of colorectal cancer. Surgery. 1999;125(4):369–374. doi: 10.1016/S0039-6060(99)70003-6.
   PubMed Web of Science ®Google Scholar
• Wolf AS, Richards WG, Jaklitsch MT, et al. Lobectomy versus sublober resection for small (2 cm or less) non-small cell lung cancers. Ann Thorac Surg. 2011;92(5):1819–1823. doi: 10.1016/j.athoracsur.2011.06.099.
   PubMed Web of Science ®Google Scholar
• Nishio W, Yoshimura M, Maniwa Y, et al. Re-assessment of intentional extended segmentectomy for clinical T1aN0 non-small cell lung cancer. Ann Thorac Surg. 2016;102(5):1702–1710. doi: 10.1016/j.athoracsur.2016.05.071.
   PubMed Web of Science ®Google Scholar
• Kawachi R, Tsukada H, Nakazato Y, et al. Early recurrence after surgical resection in patients with pathological stage I non-small cell lung cancer. Thorac Cardiovasc Surg. 2009;57(8):472–475. doi: 10.1055/s-0029-1185734.
   PubMed Web of Science ®Google Scholar
• Shiono S, Abiko M, Sato T. Positron emission tomography/computed tomography and lymphovascular invasion predict recurrence in stage I lung cancers. J Thorac Oncol. 2011;6(1):43–47. doi: 10.1097/JTO.0b013e3181f9abca.
   PubMed Web of Science ®Google Scholar
• Inoue M, Minami M, Sawabata N, et al. Clinical outcome of resected solid-type small-sized c-stage IA non-small cell lung cancer. Eur J Cardiothorac Surg. 2010;37(6):1445–1449. doi: 10.1016/j.ejcts.2009.12.030.
   PubMed Web of Science ®Google Scholar
• Shoji F, Haro A, Yoshida T, et al. Prognostic significance of intratumoral blood vessel invasion in pathologic stage IA non-small cell lung cancer. Ann Thorac Surg. 2010;89(3):864–869. doi: 10.1016/j.athoracsur.2009.09.047.
   PubMed Web of Science ®Google Scholar
• Nakao M, Yoshida J, Ishii G, et al. Prognostic impact of node involvement pattern in pulmonary pN1 squamous cell carcinoma patients. J Thorac Oncol. 2010;5(4):504–509. doi: 10.1097/JTO.0b013e3181ccb391.
   PubMed Web of Science ®Google Scholar
• Yoshizawa A, Motoi N, Riely GJ, et al. Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases. Mod Pathol. 2011;24(5):653–664. doi: 10.1038/modpathol.2010.232.
   PubMed Web of Science ®Google Scholar
• Hung JJ, Jeng WJ, Chou TY, et al. Prognostic value of the new International Association for the Study of Lung Cancer/American Thoracic Sorite/European Respiratory Society Lung Adenocarcinoma classification on death and recurrence in completely resected stage I lung adenocarcinoma. Ann Surg. 2013;258(6):1079–1086. doi: 10.1097/SLA.0b013e31828920c0.
   PubMed Web of Science ®Google Scholar
• Merritt RE, Abdel-Rasoul M, Fitzgerald M, et al. Nomograms for predicting overall and recurrence-free survival from pathologic stage IA and IB lung cancer after lobectomy. Clin Lung Cancer. 2021;22(4):e574–e583. doi: 10.1016/j.cllc.2020.10.009.
   PubMed Web of Science ®Google Scholar
• Schuchert MJ, Normolle DP, Awais O, et al. Factors influencing recurrence following anatomic lung resection for clinical stage I non-small cell lung cancer. Lung Cancer. 2019;128:145–151. doi: 10.1016/j.lungcan.2018.12.026.
   PubMed Web of Science ®Google Scholar
• National Comprehensive Cancer Network (NCCC). NCCN clinical practice guidelines in oncology. Non-Small cell lung cancer (Version 8, 2020). [cited 2020 Aug 19]. https://www.nccn.org/professionals/physician_gls/pdf/nsclc.pdf.;2020.
   Google Scholar
• Ikeda T, Kadota K, Go T, et al. Current status and perspectives of spread through air spaces in lung cancer. Thorac Cancer. 2021;12(11):1639–1646. doi: 10.1111/1759-7714.13918.
   PubMed Web of Science ®Google Scholar
• Wang BY, Huang JY, Chen HC, et al. The comparison between adenocarcinoma and squamous cell carcinoma in lung cancer patients. J Cancer Res Clin Oncol. 2020;146(1):43–52. doi: 10.1007/s00432-019-03079-8.
   PubMed Web of Science ®Google Scholar
• Cook MB, Kamangar F, Whiteman DC, et al. Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the International BEACON Consortium. J Natl Cancer Inst. 2010;102(17):1344–1353. doi: 10.1093/jnci/djq289.
   PubMedGoogle Scholar
• Marra A, Hillejan L, Zaboura G, et al. Pathologic N1 non-small cell lung cancer: correlation between pattern of lymphatic spread and prognosis. J Thorac Cardiovasc Surg. 2003;125(3):543–553. doi: 10.1067/mtc.2003.322.
   PubMed Web of Science ®Google Scholar
• Sawabata N, Miyaoka E, Asamura H, et al. Japanese lung cancer registry study of 11,663 surgical cases in 2004: demographic and prognosis changes over decade. J Thorac Oncol. 2011;6(7):1229–1235. doi: 10.1097/JTO.0b013e318219aae2.
   PubMed Web of Science ®Google Scholar
• Tao H, Hayashi T, Sano F, et al. Prognostic impact of lymphovascular invasion compared with that of visceral pleural invasion in patients with pN0 non-small-cell lung cancer and a tumor diameter of 2 cm or smaller. J Surg Res. 2013;185(1):250–254. doi: 10.1016/j.jss.2013.05.104.
   PubMed Web of Science ®Google Scholar
• Nakamura H, Sakai H, Kimura H, et al. Difference in postsurgical prognostic factors between lung adenocarcinoma and squamous cell carcinoma. Ann Thorac Cardiovasc Surg. 2017;23(6):291–297. doi: 10.5761/atcs.oa.17-00020.
   PubMed Web of Science ®Google Scholar
• Boyd JA, Hubbs JL, Kim DW, et al. Timing of local and distant failure in resected lung cancer: implications for reported rates of local failure. J Thorac Oncol. 2010;5(2):211–214. doi: 10.1097/JTO.0b013e3181c20080.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Sun Y, Xiang J, et al. A clinicopathologic prediction model for postoperative recurrence in stage Ia non-small cell lung cancer. J Thorac Cardiovasc Surg. 2014;148(4):1193–1199. doi: 10.1016/j.jtcvs.2014.02.064.
   PubMed Web of Science ®Google Scholar